Form 4 Tracker
VERTEX PHARMACEUTICALS INC / MA
VRTX

95 insider filings · Latest: Jul 21, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 2, 2026Jul 7 8:15 PMOurania TatsisEVP, Chief Reg. & Quality Off.
Sale
1,500$524.99$787.5K45,321(D)

View →

Jul 2, 2026Jul 7 8:08 PMDuncan MckechnieEVP, Chief Commercial Officer
Sale
1,541$519.00$799.8K11,001(D)

View →

Jul 1, 2026Jul 6 8:13 PMJoy LiuEVP and Chief Legal Officer
Sale
828$502.71$416.2K19,131(D)

View →

Jul 2, 2026Jul 2 8:30 PMTatsis Ourania
Proposed Sale
1,500$524.99$787.5K

View →

Jul 2, 2026Jul 2 6:16 PMMcKechnie Duncan
Proposed Sale
1,541$519.00$799.8K

View →

Jul 1, 2026Jul 1 5:00 PMLiu Joy
Proposed Sale
828$502.71$416.2K

View →

Jun 26, 2026Jun 30 8:09 PMCarmen BozicEVP and CMO
Sale
596$482.50$287.6K15,337(D)

View →

Jun 26, 2026Jun 26 1:54 PMBozic Carmen
Proposed Sale
596$482.50$287.6K

View →

Jun 18, 2026Jun 23 8:08 PMCarmen BozicEVP and CMO
Sale
1,020$462.17$471.4K15,933(D)

View →

Jun 18, 2026Jun 18 3:33 PMBozic Carmen
Proposed Sale
1,020$462.17$471.4K

View →

Jun 15, 2026Jun 17 8:12 PMCarmen BozicEVP and CMO
Sale
4,062$450.00$1.8M16,953(D)

View →

Jun 15, 2026Jun 15 7:07 PMBozic Carmen
Proposed Sale
4,062$450.00$1.8M

View →

Jun 5, 2026Jun 9 8:24 PMCarmen BozicEVP and CMO
Sale
1,745$450.00$785.3K21,015(D)

View →

Jun 5, 2026Jun 5 6:33 PMBozic Carmen
Proposed Sale
1,745$450.00$785.3K

View →

Jun 1, 2026Jun 3 8:06 PMJoy LiuEVP and Chief Legal Officer
Sale
828$439.91$364.2K19,959(D)

View →

May 29, 2026Jun 2 8:04 PMCarmen BozicEVP and CMO
Sale
1,974$450.00$888.3K22,760(D)

View →

Jun 1, 2026Jun 1 6:13 PMLiu Joy
Proposed Sale
828$439.91$364.2K

View →

May 29, 2026May 29 5:31 PMBozic Carmen
Proposed Sale
1,974$450.00$888.3K

View →

May 15, 2026May 19 8:05 PMMark E. BunnageEVP, Chief Scientific Officer
Sale
33$453.45$15.0K7,284(D)

View →

May 15, 2026May 19 8:04 PMCarmen BozicEVP and CMO
Sale
1,354$453.45$614.0K24,734(D)

View →

Page 1 of 7

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 15, 2026Jul 17 8:06 PMBruce I SachsDirector
Grant/Award
99.94115,771.807(D)

View →

Jul 15, 2026Jul 17 8:05 PMAlan M GarberDirector
Grant/Award
31.5665.458(D)

View →

May 1, 2026May 5 9:44 PMSuketu UpadhyayDirector
Grant/Award
3,662$424.453,595.156(D)

View →

May 1, 2026May 5 9:37 PMNancy ThornberryDirector
Grant/Award
1,831$424.45398(D)

View →

May 1, 2026May 5 9:29 PMJennifer SchneiderDirector
Grant/Award
2,229$424.45796(D)

View →

May 1, 2026May 5 9:24 PMBruce I SachsDirector
Grant/Award
2,866$424.452,866(D)

View →

May 1, 2026May 5 9:18 PMDiana MckenzieDirector
Grant/Award
7967,787.483(D)

View →

May 1, 2026May 5 9:06 PMMichel LagardeDirector
Grant/Award
2,866$424.452,866(D)

View →

May 1, 2026May 5 8:58 PMAlan M GarberDirector
Grant/Award
1,433$424.451,433(D)

View →

May 1, 2026May 5 8:54 PMLloyd CarneyDirector
Grant/Award
2,866$424.452,866(D)

View →

Apr 15, 2026Apr 17 8:20 PMSuketu UpadhyayDirector
Grant/Award
80.5082,799.156(D)

View →

Apr 15, 2026Apr 17 8:17 PMBruce I SachsDirector
Grant/Award
107.34515,671.866(D)

View →

Apr 15, 2026Apr 17 8:14 PMAlan M GarberDirector
Grant/Award
33.89833.898(D)

View →

Feb 19, 2026Feb 23 9:21 PMAmit SachdevEVP Chief Patient & Ext Af Off
Option Exercise
48,505$187.530(D)

View →

Jan 15, 2026Jan 20 9:48 PMSuketu UpadhyayDirector
Grant/Award
80.3162,718.648(D)

View →

Jan 15, 2026Jan 20 9:45 PMBruce I SachsDirector
Grant/Award
107.08815,564.521(D)

View →